# GnRH Agonist at Embryo Transfer: IVF Outcomes

> **NCT03544073** · PHASE3 · WITHDRAWN · sponsor: **Maimonides Medical Center**

## Conditions studied

- Infertility
- Infertility, Female
- Infertility, Male

## Interventions

- **DRUG:** Saline Solution for Injection
- **DRUG:** Leuprolide Acetate

## Key facts

- **NCT ID:** NCT03544073
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-04-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The investigators were not able to get grant funding for this study.
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03544073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03544073, "GnRH Agonist at Embryo Transfer: IVF Outcomes". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT03544073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*